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Background
Bioterrorist events can produce a variety of secondary
cardiovascular effects. For example, mass vaccination cam-
paigns to combat such potential bioterrorist agents as
smallpox can lead to cardiovascular symptoms in some of
those who receive the vaccine. The acute and posttraumatic
psychological stress experienced by those affected (directly
or indirectly) by the bioterrorist event may trigger acute
cardiovascular events (such as heart attacks, sudden deaths,
strokes) or exacerbate existing cardiovascular symptoms. In
addition, a large-scale terrorist event could overwhelm the
emergency medical and health care system, straining a
community’s ability to provide timely care for patients with
the more conventional but time-dependent medical and
surgical cardiovascular emergencies.
In this report, we describe the secondary or indirect cardio-
vascular effects of the agents and diseases that are most likely to
be used for bioterrorism. These include the impact of the stress
produced by bioterrorism on cardiovascular health and the
cardiovascular complications of smallpox vaccine. We then
describe the pathophysiological processes through which bio-
terrorist attacks could trigger cardiovascular events, followed by
suggestions for how to prevent or treat cardiovascular events
during terrorist attacks and the implications for health care
policy and future research.
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Secondary and Indirect
Cardiovascular Effects of Bioterrorism
Cardiovascular Effects of Smallpox Vaccination
Variola virus, which causes smallpox, does not produce
cardiovascular complications directly, but vaccinia virus,
which is used in the smallpox vaccine, has been linked to
cardiovascular complications, especially myocarditis and
myopericarditis (1,2). The pathogenic mechanism through
which the vaccine precipitates myocarditis remains to be
determined for 3 reasons. First, endomyocardial biopsy,
which is the gold standard for diagnosing myocarditis, has
limited sensitivity because the active inflammatory process is
frequently patchy in distribution and has a diagnostic yield
of only 10% (3). Second, because of the risks associated with
endomyocardial biopsy, it is recommended for use only in
patients with left ventricular dysfunction and symptoms not
controlled by standard medical management. Third, the
limited evidence currently available suggests that an abnor-
mal immune mechanism is responsible for the development
of myocarditis (4,5).
Several studies have examined the potential cardiovascular
effects of smallpox vaccine. For example, Murphy et al.
describe a case in which endomyocardial biopsy was obtained
and primary vaccinia infection was excluded based on negative
results of polymerase chain reaction (PCR) screening for the
vaccinia genome (4). Histopathologic findings showed a mixed
lymphocytic and eosinophilic infiltration, while immunoper-
oxidase stain demonstrated mainly CO3 T-cells and the
presence of major basic protein staining suggested an aberrant
immunologic response with an eosinophil-mediated mecha-
nism of myocyte injury. Examinations of autopsy-proven cases
of myocarditis following smallpox vaccination from the 1960s
also demonstrated both lymphocytic and eosinophilic infiltra-
tions of the myocardium.
The Department of Defense (DOD) has collected data to
determine the frequency of myopericarditis following smallpox
vaccination among 230 734 U.S. military personnel who re-
ceived vaccinia vaccines for the first time between December
2002 and March 2003 (2,4). The DOD study found that the
rate of myopericarditis was 1 in 12 819 of those who received
the vaccine for the first time. In those who developed acute
myocarditis, clinical evidence appeared at 7 to 19 days (mean
10.5 days) following vaccination. However, no cases of myo-
pericarditis developed among 95 622 individuals who received
the vaccine but had previously been vaccinated.
Currently, a potential causal link is being examined between
smallpox vaccination and ischemic cardiac events. Both fatal
and nonfatal ischemic events have occurred in civilian and
military populations 4 to 17 days following vaccination (4,6).
Analyses of incidence data on current and past cardiac events
from a vaccination campaign in New York City in 1947 did
not find an increased number of cardiac ischemic events
following smallpox vaccination (7). However, new vaccination
screening guidelines were adopted to reduce the risk of poten-
tial ischemic events by excluding individuals with known
cardiac disease or 3 or more known cardiac (ischemic) risk
factors (8).
Stress-Related Effects
Natural disasters (e.g., earthquakes and blizzards) and “unnat-
ural” disasters (i.e., caused by humans, such as missile attacks)
have been associated with an increased incidence of cardiovas-
cular events related to the sudden stress experienced by the
affected population (1–4). On the day of the 1994 earthquake
in Northridge, California, for example, the number of sudden
cardiac deaths, acute myocardial infarctions (MIs), and all
atherosclerotic ischemic heart disease deaths increased.
Increases in emotional and physical stress can stimulate the
sympathetic nervous system and increase the release of cat-
echolamines, resulting in increased blood pressure, heart rate,
and contractility (which can increase oxygen demand); changes
in sheer stress of blood against an atherosclerotic plaque, which
may contribute to its rupture; and arrhythmias. At the same
time, stimulation of alpha-receptors in the coronary arteries
increases vascular resistance and reduces blood flow, leading to
a decrease in oxygen supply.
The terrorist attacks of September 11, 2001, and the
subsequent anthrax exposures created a very high level of
psychological stress in those directly targeted as well as their
friends and relatives. The attacks also increased psychological
stress among the entire population of the U.S. Although the
stress experienced by those who were not directly affected by
the attacks may have been less severe than that experienced by
those targeted directly, it may have produced far more cardio-
vascular events because it affected millions of individuals.
However, the absolute number of cardiovascular events
throughout the U.S. did not produce an unmanageable work-
load for cardiovascular treatment facilities.
Studies examining the effect of the September 11, 2001,
terrorist attacks on cardiac event rates show mixed results. A
careful study of the cardiovascular deaths in New York City in
the month following September 11, 2001, found no increase in
cardiac mortality following the terrorist attack (9). In addition,
in 1 analysis there was no significant increase in hospital
admissions for cardiac events in a survey of several New York
City hospitals (9,10). One potential explanation for these
negative results was that patients with cardiac symptoms in
New York City may have been directed away from hospitals
near the site of attack. Conversely, a study from Brooklyn
described an increase in acute MIs and tachycardias following
the terrorist attack (11). Studies from New Jersey (12) and
Worcester, Massachusetts (13), also suggested that the terrorist
attacks increased hospitalizations for MIs in these locations
more remote from the site of attack. It is also possible that
cardiovascular events occurred at a lower level in New York
City and nationwide that was not accounted for in this index.
For example, cardiovascular events occurring in individuals
within the World Trade Center towers on September 11,
2001, would not have been measurable due to the deaths
caused by collapse of the buildings. In addition, it is not yet
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clear whether those who inhaled toxic dust following the
collapse of the World Trade Center will experience long-term
cardiovascular effects as a result. Certainly some have experi-
enced pulmonary manifestations (14).
Investigators have recently reported an increased firing of
implantable cardioverter-defibrillators (ICDs) in the New
York City area patients in the month following September 11,
2001. One study reported a 2.3-fold increase in ventricular
tachyarrhythmias in the 30 days following the attack compared
to the 30 days preceding the terrorist attack (15). Another
study by some of the same investigators observed similar
findings in Gainesville, Florida (16). However, seasonal vari-
ations in such arrhythmias and other cardiac events—which
may even occur in mild climates—were not taken into account
in these studies (17).
Pathophysiological Processes
Through Which Terrorist Attacks
Could Trigger Cardiovascular Events
Extensive data on the causes of cardiovascular events by
external events provide a basis for understanding the cardiac
events that future, potentially more widespread, attacks might
cause. The distinct patterns of the onset of many acute
cardiovascular conditions (e.g., acute MI, cardiac arrest, stroke)
indicate that these events can be triggered by factors external to
the atherosclerotic plaque.
Circadian Variation of MI
The onset of MI has a distinct pattern, with peak incidence in
the hours after awakening and arising. Serum creatine kinase
(CK) measurements obtained from 703 subjects in the MILIS
(Multicenter Investigation of Limitation of Infarct Size) study
were used to demonstrate a marked circadian variation in the
incidence of MI, with a 3-fold increase at 9 AM compared to 11
PM (18). Goldberg et al. (19) and Willich et al. (20) have
subsequently refined this evidence by determining that the
increased incidence of MI occurs within the first few hours
after awakening and onset of activity, independent of time of
day. These data indicate that the activities after awakening
trigger the onset of a sizeable percentage of acute coronary
events. Thompson et al. (21) and others (22) have suggested
that in the evening hours (between 6 PM and 12 AM), a
secondary peak of MI onset may occur. Infarcts occurring in
these hours may result from an evening meal or other triggers
concentrated in the evening hours.
A variety of factors both related to and independent of
activity level may create the milieu in the coronary plaque that
leads to an increased incidence of MI onset in the morning
hours. A morning systemic blood pressure surge due to
increased cortisol and catecholamine secretion in combination
with increased coronary artery tone could promote disruption
of a vulnerable plaque (23,24). Increased coronary artery tone
alone could worsen flow reduction produced by fixed stenoses
(24). Prothrombotic processes—including increased platelet
adhesion and aggregability (25,26), increased factor VII, and
plasminogen activator inhibitor activity (27), along with in-
creased blood viscosity (28)—have been implicated in the
onset of acute cardiac events and have been associated with
decreased effectiveness of heparin and thrombolytics in the
morning hours (29). Predisposition to plaque disruption and
subsequent thrombosis added to reduced fibrinolytic activity in
the morning could increase the likelihood that an otherwise
harmless mural thrombus overlying a small plaque fissure
would propagate and occlude the coronary lumen (30).
Epidemiologic and physiologic evidence suggests that the
periodicity of MI onset is probably due to a combination of
the true endogenous circadian rhythm and the daily rest-
activity cycle. Cortisol secretion, a determinant of systemic
blood pressure, is an established endogenous circadian
process independent of daily activity (31), while enhanced
platelet aggregability (25) and in vitro platelet responsive-
ness to adenosine diphosphate and epinephrine (26) in-
crease only after the patient awakens and assumes an upright
position. The peak morning incidence of MI probably
results from the synchronization of adverse pathophysio-
logic processes.
Weekly Variations in Acute MI
Numerous investigators have reported a circaseptan (weekly)
variation in MI onset, with a peak incidence on Mondays
(32,33). Willich et al. (32) noted that this increase occurs
primarily in the working population, who have a 33% higher
relative risk of MI on this day of the week than the
nonworking population. However, Spielberg et al. (33)
observed a Monday increase in both working and retired
subgroups. Some researchers have noted an increased inci-
dence of MI on the weekend (34), while others have
identified a weekend nadir (32).
Seasonal Variations in Acute MI and Coronary Artery
Disease Deaths
Several investigators have reported a circannual (seasonal)
variation in the incidence of acute MI onset, infarct size,
and cardiac mortality, with a peak in the winter months
(17,35,36). In the 83 541 subjects in the NRMI (National
Registry of Myocardial Infarction) database between 1990
and 1993, 10% more acute cardiac events occurred in winter
or spring than in summer (p 0.05) (35). When Spencer et
al. (36) reviewed data on 259 891 patients included in the
second NRMI study from 1994 to 1996, they noted that at
least 50% more cases of MI were reported in the winter
(peak in January) than in the summer (nadir in July). Kloner
et al. (37) demonstrated larger infarct size during the winter
months by retrospective analysis of CK enzyme release in
participants from the MILIS and Thrombolysis Myocardial
Infarction-4 trial.
Sayer et al. (38) obtained prospective data on 1225
consecutive patients with acute MI admitted to a general
hospital. Overall, these investigators noted a winter peak in
the incidence of MI onset. However, patients who were
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diabetic or of South Asian descent, or who were taking beta
blockers or aspirin on admission did not demonstrate
seasonal variation. Marchant et al. (39) noted a winter peak
in the 633 consecutive patients with acute MI admitted to
the coronary care unit during a 4-year period.
Interestingly, these authors noted an excess of infarctions
on colder days in both winter and summer, suggesting that
environmental temperature affects the onset of this disease.
Colder weather has been shown to alter hemodynamic
(blood pressure, sympathetic tone) and hematologic (plate-
let count, fibrinogen) factors favoring arterial thrombosis
(40). In addition, cold weather may be associated with an
increase in oxygen demand from such activities as shoveling
snow and with an increase in the rate of respiratory
infections (39). However, the increase in the incidence of
cardiac events does not appear to depend on temperature
alone. Even in the relatively mild climate of Los Angeles
County, a study of 220 000 subjects revealed a peak cardiac
death rate in December and January (17). The potential
roles in MI onset played by dietary and psychological
changes around the holidays, as well as the seasonal decrease
in number of daylight hours, are under investigation.
Other Cardiovascular Triggers
The circadian, circaseptan, and circannual variations in the
incidence of MI onset suggest that the onset of acute cardiac
events is not random and can be triggered by endogenous
rhythms in combination with external activities and expo-
sures. The MIOS (Myocardial Infarction Onset Study)
investigators have identified several of the activities and
exposures that can trigger MI onset, including heavy phys-
ical exertion, anger, mental stress, sexual activity, cocaine
use, marijuana use, and air pollution (41–45). According to
these investigators, these triggers account for over 20% of
infarctions, totaling more than 250 000 events, in the U.S.
each year.
Heavy Physical Exertion
Several studies have identified heavy physical exertion as a
trigger of acute MI. The MILIS trial (46), for example,
found that 14% of patients engaged in moderate physical
activity and 9% engaged in heavy physical activity prior to
experiencing an MI. In the TIMI-2 trial (47), moderate or
marked physical activity was reported at MI onset in 18.7%
of patients. Compared to patients whose infarction occurred
at rest or during mild activity, those with exertion-related
infarction had fewer coronary vessels with greater than 60%
stenosis and were more likely to have an occluded infarct-
related vessel after thrombolytic therapy. Support for heavy
exertion as a cause of plaque disruption has been further
strengthened by an autopsy series on men who had died
suddenly (48). Those who died during exertion were much
more likely to demonstrate a plaque with a ruptured cap
than those who died at rest.
Fifty-four (4.4%) of 1228 patients enrolled in the MIOS
trial reported heavy exertion (6 or more metabolic equiva-
lents) within 1 h of the onset of MI (41). The cardiac
symptoms often began during the activity. Using the case-
crossover study design developed by Maclure (49), the
estimated relative risk of MI in the hour after heavy physical
activity was 5.9 compared to less strenuous or no physical
exertion. Relative risks were 107 among people who usually
exercised less than once a week, 19.4 in those who exercised
once or twice a week, 8.6 in those who exercised 3 to 4 times
a week, and 2.4 in those who exercised 5 or more times per
week. Therefore, habitually sedentary individuals were at
greatest risk of MI after heavy exertion and increasing levels
of regular physical exercise were associated with progres-
sively lower coronary risk. Similarly, exercise appears to
protect individuals from sudden cardiac death associated
with heavy physical exertion (48,50).
Proposed mechanisms for triggering MI onset by heavy
exertion include increased sympathetic nervous system ac-
tivation leading to increased myocardial oxygen demand
(50) and increased platelet activation in sedentary patients
and those with prior MI (51). Interestingly, heavy exertion
does not cause platelet activation in healthy active volun-
teers, which may help explain the protective effect of regular
exercise. Additional benefits of regular exercise include
blunted up-regulation of the sympathetic nervous system
during exertion and activation of the fibrinolytic system
(52). Thus, a patient’s propensity for developing MI during
or after heavy exertion appears to depend, in part, on the
degree of sympathetic activity and of balance between
prothrombotic and fibrinolytic effects. Despite the proposed
importance of sympathetic activation and the potential net
prothrombotic effect, it remains unclear whether beta block-
ers or aspirin decrease the relative risk of MI triggered by
exertion.
Anger
The MIOS investigators interviewed 1623 individuals ap-
proximately 4 days after they experienced an acute MI to
assess the intensity and timing of discrete episodes of anger
(and other triggers) during the 26 h before the acute event
(42). Anger was objectively assessed by the onset anger scale
(a single-item, 7-level, self-report scale) and the state anger
subscale of the State–Trait Personality Inventory. Based on
the onset anger scale, 39 patients (2.4%) had experienced
anger within the 2 h prior to onset of MI. This corre-
sponded to a relative risk of MI of 2.3 in the 2 h following
an outburst of anger relative to a control period using the
case-crossover method (53). The state anger subscale cor-
roborated these findings with a relative risk of 1.9. Of note,
the relative risk of MI within the 2 h following an outburst
of anger for patients on aspirin was 1.4, significantly lower
than for those not on aspirin (p  0.05), suggesting a
possible role for aspirin in the prevention of anger-triggered
MI onset. Reich et al. (54) noted that anger was the
probable trigger for 15% of the life-threatening arrhythmias
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in the 117 patients they studied. Fear, anxiety, and bereave-
ment have also been implicated in an increased risk of
cardiac events.
Mental Stress
Acute mental stress may be a trigger of transient myocardial
ischemia (53,55), MI (56), and sudden cardiac death
(57,58). Bairey et al. (53) noted that 75% of 29 patients with
coronary artery disease and exercise-induced myocardial
ischemia also demonstrated mental stress-induced wall mo-
tion abnormalities by radionuclide ventriculography. Barry
et al. (55) performed ambulatory electrocardiographic mon-
itoring supplemented with daily records in 28 subjects with
coronary artery disease. The ECG monitoring identified
372 episodes of ST-segment depression over a span of 5 to
6 weeks. At least 22% of the ischemic episodes occurred at
high levels of mental stress but low physical activity. In
addition, transient ischemia was more likely to occur as the
intensity level of mental activity increased.
Long-Term Cardiovascular Sequelae
The aforementioned studies indicate that a bioterrorist
attack might trigger acute cardiovascular events among
those who were not directly exposed to the attack. The
kinds of terrorist attacks that have occurred in the past, such
as airplane hijackings and car bombings, are unlikely to
trigger cardiovascular events long after the event, although
any acute events (congestive heart failure resulting from
nonfatal MI) triggered immediately after the event could
have long-term cardiovascular effects. However, other types
of potential terrorist attacks, such as exposing a population
to a virus that leads to inflamed plaques or cardiomyopathy
might produce a massive number of cardiovascular events
long after the attack occurred.
Preventing and Treating Cardiovascular
Events During Terrorist Attacks
Pharmacoprevention
Given the compelling data on the circadian variation of MI
onset, most physicians provide pharmacologic protection
during the morning hours for patients already receiving
anti-ischemic and antihypertensive therapy (18,19,59).
Varying levels of evidence show that the 4 classes of agents
most commonly administered to prevent acute coronary
events (lipid-lowering agents, angiotensin-converting en-
zyme inhibitors, beta-adrenergic blocking agents, and aspi-
rin) render plaques less likely to be disruptive. Lowering
low-density lipoprotein levels to below 60 mg/dl, for exam-
ple, appears to prevent infarction and death by stabilizing
vulnerable plaques, and aspirin use has been associated with
a reduced risk of anger-triggered MI onset. However,
further study is needed to define the role of additional
agents in trigger modulation (42).
The high likelihood that a terrorist attack will trigger
acute cardiovascular events has led to questions about the
need for preventive therapy in the event of a terrorist attack.
The advisability of giving beta blockers or aspirin to the
entire at-risk population when news of an attack is publi-
cized must take into account the difference between absolute
and relative risk of triggering. While it is true that some
potent triggers, such as cocaine, increase the risk of an MI
20-fold (relative risk increase), the absolute risk that a
50-year-old, nonsmoking, nondiabetic male will have an MI
in any given hour is 1 out of 1 million. The absolute number
of infarctions that would result from a terrorist attack,
therefore, is likely to be very low. As a result, the potential
benefits of mass administration of beta blockers, aspirin, or
other agents to millions of individuals are likely to be low,
especially when compared to the side effects associated with
these agents. The fact that the incidence of cardiovascular
mortality did not increase in New York City after Septem-
ber 11, 2001, supports this conclusion (9).
The most promising approach to the prevention of
cardiovascular events triggered by a conventional terrorist
attack would be to improve methods for preventing such
events in general. Improved methods to detect and treat
vulnerable atherosclerotic plaques would protect the popu-
lation against the many potential triggers that they experi-
ence daily, as well as the rare trigger of a massive terrorist
attack. Furthermore, physical conditioning could also help
reduce the likelihood of a stress-induced MI.
The additional threat remains that terrorists might
launch a bioterrorism attack using a microorganism or toxin
that causes cardiovascular disease, either by worsening
atherosclerosis or directly attacking the cardiovascular sys-
tem. The best defense against such an attack is continued
research on the types of agents that might be used in such
attacks and the development of drugs and vaccines to
counteract their effects.
Surge Capacity for Emergency Medical Services
A bioterrorist attack is likely to have a significant, sustained,
and harmful effect on the affected community’s ability to
manage everyday medical and surgical emergencies, similar
to what commonly occurs following natural disasters (e.g.,
hurricanes, earthquakes, floods) (60–78). For example, in
the 1 to 3 weeks following a major hurricane, the emergency
department (ED) volume increases 17% to 40%, mostly due
to an increase in patient visits relating to lacerations of all
types, puncture wounds, stings, and falls (65,67). Unfortu-
nately, sudden peaks in demand for emergency care are
becoming increasingly difficult to handle because hospital
surge capacity has eroded dramatically in the last decade due
to: 1) decreased reimbursement by managed care organiza-
tions for inpatient care, resulting in a nationwide reduction
of hospital beds, 2) the nursing shortage, 3) a more acute
patient mix, and 4) a general deterioration in the health care
safety net and an increase in ED visits by uninsured patients
who cannot afford routine medical care (79).
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Because of these factors, the EDs are overcrowded and
ambulances are frequently diverted from their original
destinations (80–83). The deleterious effects of ED over-
crowding and ambulance diversion are most evident in
patients with life-threatening cardiovascular conditions
(e.g., cardiac arrest, heart attack, and stroke) for which
effective, but highly time-dependent, treatments are avail-
able. Schull et al. (82) have shown that ED overcrowding is
associated with significant increases in emergency medical
services’ ambulance response times and transport intervals
for patients with chest pain.
The effect of a terrorist attack on the health care system,
and on the care of patients with cardiovascular problems in
particular, will depend on the number of victims who
survive and the need significant medical care, the nature of
the attack, and how long the influx of patients and need for
care continues. Following the World Trade Center attack
on September 11, 2001, the New York metropolitan area
health care system focused its attention on the hundreds of
injured survivors, discharging patients with less critical
problems and deferring their care. Because the event re-
sulted in only a single burst of patients and did not threaten
the hospitals directly, mortality of cardiac patients did not
increase in the month following the attack compared to
pre-attack control figures (9). However, on the first day of
the 1991 Gulf War, the number of deaths from suffocation,
asphyxiation, aspiration, MI, cardiac arrest, and cerebrovas-
cular accidents increased abruptly in Israel, as did the
number of sudden deaths associated with the use of tight-
fitting masks with filters in sealed rooms. Much of the
excess risk of death from cardiorespiratory complications
during the first air raid alert may have been due to its
duration (140 min).
A bioterrorism attack that leads to thousands or more of
victims over a period of days, weeks, or months could have
a catastrophic effect on health care facilities in the U.S. If
the attack involved a highly infectious agent associated with
high morbidity and mortality rates, particularly one for
which immunization or effective prophylaxis does not exist,
health care and public safety personnel (including police,
firefighters, emergency medical technicians and paramedics,
nurses, physicians) might not be willing to report for duty
out of concern for their personal safety or to care for their
own families. During such an event, Veterans Affairs and
military hospitals, National Guard personnel and disaster
management assistance teams, and other resources would
probably be deployed, but this would typically take 12 to
24 h unless advance warning of the attack triggers activation
and predeployment.
Cardiovascular (and presumably all other) emergency care
would be highly compromised under such circumstances.
Plans need to be developed to ensure emergency treatment
and continuity of care (including supplies of needed medi-
cations) during a bioterrorist incident for those with known
or emerging cardiovascular disease. Once the acute crisis
subsides, more emphasis will need to be placed on managing
the mental and physical effects of the attack on the survivors
and community at large.
Hospital surge capacity must be increased to accommo-
date the long-term consequences of a widespread, ongoing
bioterrorism attack. The initial focus should be on the large
Level 1 trauma center facilities throughout the country,
particularly those that serve areas at increased risk of a
terrorist attack based on Department of Homeland Security
assessment.
The most promising new concept to emerge recently is
ER One, a new congressionally funded ED renovation plan
developed for the Washington Hospital Center. ER One
allows a standard 60- to 70-bed ED to accommodate 4
times that number of patients with a less than 30-min notice
and increase its normal patient volume 10-fold with only a
few hours’ notice. The design calls for rooms that are larger
than standard size and can accommodate multiple patients
during surges using collapsible walls to open up work areas.
All medical equipment is modular and wired into the
ceilings, allowing rapid influx of critical equipment in times
of crisis. All public areas (corridors, waiting and registration
areas, office spaces) are pre-wired and configured to be
turned into patient care areas on short notice. Furthermore,
all rooms are negative-pressure capable, allowing the ED to
function effectively during a widespread bioterrorism attack.
Data and Health Care Policy Implications
Currently, the U.S. cannot track the incidence and out-
comes of common cardiovascular emergency conditions
(including heart attack, sudden death, and stroke) or quan-
tify the direct and indirect cardiovascular effects of a
bioterrorist event. A sophisticated tracking system is needed
to provide early alerts concerning biological attacks, as well
as outbreaks (e.g., influenza, SARS) that are not related to
terrorism but could have a major impact on a population’s
health, including its cardiovascular health. A real-time
electronic epidemiological and syndromic surveillance sys-
tem is critically needed to track the types and numbers of
patients with similar symptoms and diseases, beginning in
the emergency medical system and continuing through the
ED and hospital phases of care.
As more and more emergency medical, ED, and hospital
systems convert to electronic medical records, common data
elements with standardized definitions should be linked.
Software manufacturers that produce electronic medical
record products should be required to collect certain uni-
formly defined data elements that will support this Depart-
ment of Homeland Security goal and build links into their
program to export these encrypted data into a real-time
national surveillance system. The system should also include
a method to de-identify patient data early in the process to
comply with HIPAA. Although the primary purpose of
such a system would be to protect national security, it could
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be used to increase the quality of care and support such
government programs as Healthy People 2010 (84).
Recommendations
1. Additional research is needed on the cardiovascular
complications of vaccines to determine whether indi-
viduals who react unfavorably can be identified pro-
spectively and whether more effective preventive and
therapeutic interventions are available for those who
experience such complications.
2. Additional research is needed on the links between
psychological stress and acute cardiovascular events,
particularly with respect to whether any additional
prophylactic measures can be used for individuals at
increased risk.
3. Data should be collected from ICDs at the time of a
bioterrorism incident to provide critical information on
the effects of the associated stress on cardiac arrhyth-
mias.
4. Further research is needed on the chronic, long-term
effects of bioterrorist attacks.
5. The federal government should provide funds to help
hospitals with trauma centers improve their surge
capacity using the ER-One design. Such units must be
staffed with adequately trained personnel who can
sustain their functions during incidents that last for
weeks or months.
6. Health care providers should be trained on how to
address the consequences of a bioterrorism attack,
including how and when to use personal protective
equipment, and what information to report and to
whom. Such training is now available through nation-
ally standardized courses in core, basic, and advanced
disaster life support (85,86).
7. Provide training to increase the general public’s capa-
bility to help manage acute cardiovascular conditions.
This should include recognizing acute cardiovascular
conditions, calling 911 to report suspected events,
performing cardiopulmonary resuscitation, and using
automated external defibrillators (this is consistent
with the Healthy People 2010 objectives). In addition,
more large public facilities should be equipped with
automated external defibrillators (87).
8. Establish a real-time, electronic epidemiological and
syndromic surveillance system that can track the inci-
dence of cardiovascular conditions (heart attack, sud-
den death, and stroke) that might be affected by a
bioterrorist event.
9. Require manufacturers that produce electronic medical
record products to collect certain uniformly defined
data elements that will support this Homeland Security
purpose and build links into the program that will
export these encrypted data into a real-time national
surveillance system.
10. Increase partnerships among multiple federal, state,
local, public health, military, and private organizations
to provide comprehensive, coordinated training, and
response to a bioterrorist event.
11. Increase emphasis on preventing cardiovascular dis-
ease, including modifying risk factors.
Summary
In this report, we have discussed some of the secondary or
indirect cardiovascular effects of the agents and diseases that
are most likely to be used for bioterrorism, including the
cardiovascular complications of the smallpox vaccine and
the impact of the stress and anger produced by bioterrorism
on both short- and long-term cardiovascular health. The
pathophysiological processes through which bioterrorist at-
tacks could trigger cardiovascular events include circadian
variation of MI. We proposed that hospitals adopt plans,
such as ER One, to increase their surge capacity quickly
when needed to respond to a bioterrorist attack. In our
recommendations, we called for additional research on the
cardiovascular complications of the smallpox vaccine, the
links between psychological stress and acute cardiovascular
events, the effects of stress on cardiac arrhythmias, and the
long-term cardiovascular effects of bioterrorism. Other rec-
ommendations were to train health care providers in ad-
dressing the indirect and secondary cardiovascular effects of
bioterrorism, focus on preventing cardiovascular disease to
reduce the risk of complications during a bioterrorist attack,
and develop a surveillance system to monitor cardiovascular
events associated with bioterrorism.
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